… effect of chemotherapy in broad classes of non-small cell lung cancer Modern chemotherapy
regimens may have a role in treating all stages of non-small cell lung cancer, although …

… Adjuvant chemotherapy (AC) plays now a significant role in the treatment of resected non-small
cell lung cancer (NSCLC) patients and has become standard in clinical practice. It took …

… cancer has expanded significantly, particularly in the last few years with the proven benefit
… chemotherapy. For advanced stage non-small cell lung cancer (NSCLC), chemotherapy …

… Lung cancer is classified into two main histological groups: non-small cell lung cancer (NSCLC)
and small cell lung cancer (SCLC) (Inamura 2017). NSCLC accounts for 80–85% of all …

The treatment of advanced non-small cell lung cancer (NSCLC) may be changing, but the
cisplatin-based doublet remains the foundation of treatment for the majority of patients with …

… include MRP (for platinum-based combination chemotherapy) and MDR1/P-gp (for non-…
appears to predict chemotherapy benefit in SCLC. In non-small cell lung cancer (NSCLC), the …

… who had surgery without chemotherapy (with or without radiotherapy). We found that it was
not clear whether chemotherapy helped patients with non‐small cell lung cancer live longer. …

… cancer combined. The median survival of patients with untreated metastatic non–small-cell
lung cancer is … Chemotherapy for advanced non–small-cell lung cancer is often considered …

… We randomly assigned 230 patients with metastatic, non–small-cell lung cancer and EGFR
mutations who had not previously received chemotherapy to receive gefitinib or carboplatin–…

… chemotherapy have shown improved survival for patients with non-small-cell lung cancer
(… to establish the effect of preoperative chemotherapy for patients with resectable NSCLC. …